Pozen: ROTH Conference (Pozen) - Mar 20, 2013 - Anticipated NDA submission for secondary prevention of cardiovascular disease in patients at risk for aspirin-induced ulcers by April 2013; Anticipated commercial partnership in US in 2013
Anticipated licensing / partnership • Anticipated NDA • Acute Coronary Syndrome
|